Ann: DMX-200 COVID-19 Study Opens More Sites in Europe and UK, page-40

We all are, or put it this way, we don't have any other choice but to be optimistic... lol...

I still think, partnership for DKD that comes at a Low upfront cost risk fo partner but enough for us to sustain entire P3 FSGS trial and next two years ongoing expenses can be a mid way solution....

Something upfront 30-50m + additional payments on positive interim data plus future sales royalties....
this assumes of course potential partner trust the data on DKD as much as we do!!

May be something happening in back ground on DKD with partners else I really don't understand why it will take 12 months on analysing next steps for DKD since the trial read out....